{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T10:30:49Z","timestamp":1774434649364,"version":"3.50.1"},"reference-count":18,"publisher":"Japanese Society of Internal Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,5,15]]},"DOI":"10.2169\/internalmedicine.8254-21","type":"journal-article","created":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T22:14:08Z","timestamp":1636150448000},"page":"1503-1509","source":"Crossref","is-referenced-by-count":2,"title":["Hematochezia Due to Panitumumab-induced Colitis with Vitamin K Deficiency"],"prefix":"10.2169","volume":"61","author":[{"given":"Hotaka","family":"Tamura","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Nakashima","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"Uchiyama","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Souichiro","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Hatada","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Uchida","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Ozono","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Division of Oncopathology and Regenerative Biology, Department of Pathology, Faculty of Medicine, University of Miyazaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Yamamto","sequence":"additional","affiliation":[{"name":"Division of Oncopathology and Regenerative Biology, Department of Pathology, Faculty of Medicine, University of Miyazaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kawakami","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Douillard JY, Siena S, Cassidy J, et al. Randomized phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study. J Clin Oncol 28: 4697-4705, 2010.","DOI":"10.1200\/JCO.2009.27.4860"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Peeters M, Price TJ, Cervantes A, et al. Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer. J Clin Oncol 28: 4706-4713, 2010.","DOI":"10.1200\/JCO.2009.27.6055"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Van Cutsem E, Peeters M, Siena S, et al. Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer. J Clin Oncol 25: 1658-1664, 2007.","DOI":"10.1200\/JCO.2006.08.1620"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Amado RG, Wolf M, Peeters M, et al. Wild-type <i>KRAS<\/i> is required for panitumumab efficacy in patients with metastatic colorectal cancer. J Clin Oncol 26: 1626-1634, 2008.","DOI":"10.1200\/JCO.2007.14.7116"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Loriot Y, Perlemuter G, Malka D, et al. Drug Insight: gastrointestinal and hepatic adverse effects of molecular-targeted agents in cancer therapy. Nat Clin Pract Oncol 5: 268-278, 2008.","DOI":"10.1038\/ncponc1087"},{"key":"6","unstructured":"6. Mijares ME, Nagy E, Guerrero B, Arocha-Pi\u00f1ango CL. Vitamin K: biochemistry, function, and deficiency. Invest Clin 39: 213-229, 1998."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Andreyev J, Ross P, Donnellan C, et al. Guidance on the management of diarrhea during cancer chemotherapy. Lancet Oncol 15: 447-460, 2014.","DOI":"10.1016\/S1470-2045(14)70006-3"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Benson AB, Ajani JA, Catalano RB, et al. Recommended guidelines for the treatment of cancer treatment-induced diarrhea. J Clin Oncol 22: 2918-2926, 2004.","DOI":"10.1200\/JCO.2004.04.132"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Symonds RP. Treatment-induced mucositis: an old problem with new remedies. Br J Cancer 77: 1689-1695, 1998.","DOI":"10.1038\/bjc.1998.279"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Hamouda N, Sano T, Oikawa Y, et al. Apoptosis, dysbiosis and expression of inflammatory cytokines are sequential events in the development of 5-fluorouracil-induced intestinal mucositis in mice. Basic Clin Pharmacol Toxicol 121: 159-168, 2017.","DOI":"10.1111\/bcpt.12793"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Sonis ST. The pathobiology of mucositis. Nat Rev Cancer 4: 277-284, 2004.","DOI":"10.1038\/nrc1318"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Gibson RJ, Bowen JM, Inglis MR, Cummins AG, Keefe DM. Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer. J Gastroenterol Hepatol 18: 1095-1100, 2003.","DOI":"10.1046\/j.1440-1746.2003.03136.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. H\u00f6genauer C, Langner C, Beubler E, et al. Klebsiella oxytoca as a causative organism of antibiotic-associated hemorrhagic colitis. N Engl J Med 355: 2418-2426, 2006.","DOI":"10.1056\/NEJMoa054765"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Price AB. Pathology of drug-associated gastrointestinal disease. Br J Clin Pharmacol 56: 477-482, 2003.","DOI":"10.1046\/j.1365-2125.2003.01980.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Saito D, Hayashida M, Sato T, et al. Evaluation of the drug-induced lymphocyte stimulation test for diagnosing mesalazine allergy. Intest Res 16: 273-281, 2018.","DOI":"10.5217\/ir.2018.16.2.273"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Fusaro M, Gallieni M, Rizzo A, et al. Vitamin K plasma levels determination in human health. Clin Chem Lab Med 55: 789-799, 2017.","DOI":"10.1515\/cclm-2016-0783"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Crowther MA, Julian J, McCarty D, et al. Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomized controlled trial. Lancet 356: 1551-1553, 2000.","DOI":"10.1016\/S0140-6736(00)03125-1"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Sokoll LJ, Sadowski JA. Comparison of biochemical indexes for assessing vitamin K nutritional status in a healthy adult population. Am J Clin Nutr 63: 566-573, 1996.","DOI":"10.1093\/ajcn\/63.4.566"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/10\/61_8254-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T03:33:02Z","timestamp":1653103982000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/10\/61_8254-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,15]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.8254-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,15]]},"article-number":"8254-21"}}